Apros Therapeutics

Manufacturing · 1-10 Employees

View Company Info for Free

Overview

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Apros Therapeutics

Apros Therapeutics is a drug discovery and development company specializing in tissue-targeted small molecule innate immune agonists aimed at enhancing tumor immunogenicity. Their innovative approach focuses on turning cold tumors into hot tumors by utilizing novel chemistry to precisely target agonists to specific tissues with minimal systemic distribution. The company’s pipeline includes various programs, such as oral and intranasal TLR7 agonists for cancer and viral infections. Apros Therapeutics targets clients in the oncology and infectious disease sectors, seeking to improve the efficacy of current cancer immune therapies.Explore more
Apros Therapeutics's Social MediaPopular SearchesApros Therapeutics IncSIC Code 28,283NAICS Code 32,325Show more

Apros Therapeutics Org Chart

PhoneEmail
DP

Research Scientist & Senior Scientific Associ...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Apros Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Apros Therapeutics

Compare insights from companies similar to Apros Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Apros Therapeutics

<$5M
1-10
Private
-
2016
DP
David PlouffeResearch Scientist & Senior Scientific Associate
$6.5M
11-50
Public
$340.5M
2015
JP
Jason PtacekDirector of Translational Science and Biomarkers
<$5M
11-50
Private
$30.4M
2017
YC
Yan ChenPresident & CEO
<$5M
11-50
Private
$45.6M
2016
Niranjan Sardesai, Founder, President & Chief Executive Officer at Geneos Therapeutics
Niranjan SardesaiFounder, President & CEO
<$5M
11-50
Private
-
2015
<$5M
1-10
Private
-
-
Michal Silverberg, Managing Director at Novartis Venture Fund
Michal SilverbergManaging Director
1-10
Public
$96.1M
2006
Matt Angel, President & Chief Executive Officer at Tempest Therapeutics
Matt AngelPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Apros Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Apros Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Apros Therapeutics.

Apros Therapeutics Tech Stack

A closer look at the technologies used by Apros Therapeutics

Apros Therapeutics News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Apros Therapeutics

What is Apros Therapeutics's official website?
Apros Therapeutics's official website is www.aprostx.com
What is Apros Therapeutics's Revenue?
Apros Therapeutics's revenue is <$5 Million
What is Apros Therapeutics's SIC code?
Apros Therapeutics's SIC: 28,283
What is Apros Therapeutics's NAICS code?
Apros Therapeutics's NAICS: 32,325
How many employees does Apros Therapeutics have?
Apros Therapeutics has 1-10 employees
What industry does Apros Therapeutics belong to?
Apros Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Apros Therapeutics competition?
Apros Therapeutics top competitors include: Bolt Biotherapeutics, Tempest Therapeutics, Revitope Oncology, Geneos Therapeutics
What technology does Apros Therapeutics use?
Some of the popular technologies that Apros Therapeutics uses are: Microsoft IIS, reCAPTCHA, Google Cloud DNS, Cloudflare CDN
What does Apros Therapeutics do?

Apros Therapeutics is a drug discovery and development company specializing in tissue-targeted small molecule innate immune agonists aimed at enhancing tumor immunogenicity. Their innovative approach focuses on turning cold tumors into hot tumors by utilizing novel chemistry to precisely target agonists to specific tissues with minimal systemic dis... tribution. The company’s pipeline includes various programs, such as oral and intranasal TLR7 agonists for cancer and viral infections. Apros Therapeutics targets clients in the oncology and infectious disease sectors, seeking to improve the efficacy of current cancer immune therapies.Read More

What are Apros Therapeutics social media links?
Apros Therapeutics Linkedin page
Is Apros Therapeutics a public company?
Apros Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Apros Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.